Geron (GERN) Current Leases (2019 - 2026)
Geron's (GERN) quarterly Current Leases came in at $1.0 million in Q1 2026, up 2.65% year-on-year from $981000.0 in Q1 2025, and up 0.7% quarter-over-quarter from $1.0 million in Q4 2025.
Geron (GERN) Current Leases (2019 - 2026) Analysis & Trends
Geron has disclosed Current Leases across 8 years of filings, most recently posting $1.0 million for Q1 2026.
- Current Leases for Q1 2026 came in at $1.0 million, up 2.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.0 million (up 2.65% YoY), and the FY2025 annual result was $1.0 million, up 2.67% from the prior year.
- Current Leases came in at $1.0 million for Q1 2026 at Geron, up from $1.0 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.0 million in Q1 2026 to a low of $786000.0 in Q2 2023.
- The 5-year median for Current Leases is $955000.0 (2024), against an average of $947058.8.
- Across the five-year window, Current Leases declined 13.91% in 2023 and advanced 22.26% in 2024, its largest moves.
- Geron's Current Leases stood at $925000.0 in 2022, then climbed by 2.59% to $949000.0 in 2023, then increased by 2.63% to $974000.0 in 2024, then grew by 2.67% to $1.0 million in 2025, then rose by 0.7% to $1.0 million in 2026.
- The last three Current Leases figures came in at $1.0 million (Q1 2026), $1.0 million (Q4 2025), and $994000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 42,980.09 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Geron | 729,618.77 | 729,618.77 | - | 1.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.01 Mn |
| Dec 31, 2025 | 1.00 Mn |
| Sep 30, 2025 | 994,000.00 |
| Jun 30, 2025 | 987,000.00 |
| Mar 31, 2025 | 981,000.00 |
| Dec 31, 2024 | 974,000.00 |
| Sep 30, 2024 | 968,000.00 |
| Jun 30, 2024 | 961,000.00 |
| Mar 31, 2024 | 955,000.00 |
| Dec 31, 2023 | 949,000.00 |
| Sep 30, 2023 | 943,000.00 |
| Jun 30, 2023 | 786,000.00 |
| Mar 31, 2023 | 931,000.00 |
| Dec 31, 2022 | 925,000.00 |
| Sep 30, 2022 | 919,000.00 |
| Jun 30, 2022 | 913,000.00 |
| Mar 31, 2022 | 907,000.00 |
| Dec 31, 2021 | 901,000.00 |
| Sep 30, 2021 | 895,000.00 |
| Jun 30, 2021 | 889,000.00 |